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It is a well-known fact that infectious microorganisms, i.e. bac-
teria and fungi, cause serious diseases and are responsible for
nearly one-half of the deaths in India. Benzothiazole deriva-
tives are fascinating chemical products used in the ﬁeld of med-
icine as they have been found to possess a wide spectrum of
biodynamic properties. Many of them have been reported to
have antitumor (Aiello et al., 2008), antimicrobial (Sareen
et al., 2006), antileishmanial (Delmas et al., 2004), anticonvul-
sant (Ugale et al., 2012), antidiabetic (Pattan et al., 2005), and
anti-inﬂammatory (Venkatesh and Pandeya, 2009) activities.
For this study we have prepared novel derivatives ofdiaminothiazoloylbenzothiozoles 3a–i (see Table 4). All the
synthesized compounds were screened for their antibacterial,
antifungal and antituberculosis activities.
2. Experimental
2.1. Materials and methods
The reagents and solvents used were of AR grade. All chemi-
cals were purchased from Merck Specialities Pvt. Ltd. and
HiMedia Laboratories Pvt. Ltd.
The spectra were recorded on JEOL DRX 300 or DPX 300
NMR spectrometer (300 MHz for 1H and 75 MHz for 13C
NMR spectra), JEOL SX 102/DA-6000 mass spectrometer
(using argon/xenon, 6 kV, 10 mA as the FAB gas and m-nitro-
benzyl alcohol as the matrix) for FAB mass spectra and Nico-
let 400D FTIR spectrometer. Melting points were uncorrected.
Elemental analysis was done at the Central Drug Research
Institute, India.
Scheme 1 Synthetic route of molecule 3.
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alkyl aminothiazol-5-oyl)benzothiazoles 3a–i
The reaction sequences employed for the synthesis of title com-
pounds are shown in Scheme 1. 2-(4-Amino-2-aryl/alkyl amin-
othiazol-5-oyl)benzothiazoles 3a–i were prepared according to
the following method (Abbs Fen Reji et al., 2009).
A solution of 1-aryl/alkyl-3-(N-nitroamidino)thiourea 1a–i
(1 mmol) in DMF (2 mL) was added to a solution of 2-(2-
bromoacetyl)benzothiazole 2 (0.254 g, 1 mmol), which was
prepared from 2-(1-hydroxyethyl)benzothiazole (Sawhney
and Singh, 1970; Gupta et al., 1980; Joshua and Rajasekharan,
1974; Hunter, 1925a,b, 1926) in DMF (2 mL). The reaction
mixture was stirred well and triethylamine (0.15 mL, 1 mmol)
was added. The reaction mixture was warmed at 35–40 C
for 10 min. It was then cooled and poured into ice-cold water
with constant stirring. A yellowish orange precipitate thus ob-
tained was ﬁltered, washed with water and dried. The crude
product was crystallized from methanol:water (2:1) and then
from benzene:petroleum ether (1:1) to give a yellowish orange
crystalline solid.
2.3. 2-(4-Amino-2-phenylaminothiazol-5-oyl)benzothiazole 3a
Yield 60%, m.p. 293–95 C Analysis: Found: C, 57.75: H,
3.50: N, 15.69%; Calc. for C17H12N4OS2 (352.43): C, 57.93:
H, 3.43: N, 15.90%; IR (KBr) cm1: 3454, 3285, 3137, 3103,
3050, 1625, 1599, 1566, 1526, 1499, 1445, 1356, 1237, 1188,
1034, 891, 749, 690; 1H NMR: (300 MHz, DMSO-d6) d: 7.12
(t, J= 7.35 Hz, 1H, 1ArH), 7.40(t, J= 7.8 Hz, 2H, 2ArH),
7.49–7.65 (m, 2H, H-5, H-6), 7.72 (d, J= 8.1 Hz, 2H,
2ArH), 8.09 (d, J= 8.1 Hz, 1H, H-4), 8.20(d, J= 7.8 Hz,
1H, H-7), 8.64 (br, 1H, NH), 8.76 (br, 1H, NH), 11.08 (s,
1H, NH);13C NMR: (75 MHz, DMSO-d6) d: 91.1, 119.4,
122.9, 123.7, 123.9, 126.6, 126.9, 129.1, 135.9, 139.3, 152.9,
168.7, 169.6, 170.6, 171.3; FABMS: 353 (MH+).
2.4. 2-[4-Amino-2-(4-chlorophenylamino)thiazol-5-
oyl]benzothiazole 3b
Yield 59%, m.p. 335–38 C Analysis: Found: C, 52.57: H,
2.79: N, 14.65%; Calc. for C17H11ClN4OS2 (386.88): C,
52.77: H, 2.87: N, 14.48%; IR (KBr) cm1: 3461, 3272, 3210,
3136, 3083, 1634, 1605, 1526, 1492, 1465, 1357, 1256, 1189,
1093, 892, 825, 757, 667; 1H NMR: (300 MHz, DMSO-d6) d:
7.44 (d,J= 9 Hz, 2H, 2ArH), 7.51–7.67 (m, 2H, H-5, H-6),
7.76 (d,J= 8.7 Hz, 2H, 2ArH), 8.10 (d,J= 7.8 Hz, 1H, H-
4), 8.21 (d, J= 7.8 Hz, 1H, H-7), 8.69 (br, 1H, NH), 8.72
(br, 1H, NH), 11.18 (s, 1H, NH); FABMS: 387 (MH+).2.5. 2-[4-Amino-2-(4-methoxyphenylamino)thiazol-5-
oyl]benzothiazole 3c
Yield 63%, m.p. 254–55 C Analysis: Found: C, 56.30: H,
3.75: N, 14.80%; Calc. for C18H14N4O2S2 (382.46): C, 56.52:
H, 3.69: N, 14.65%; IR (KBr) cm1: 3455, 3293, 3187, 3067,
2931, 2842, 1617, 1537, 1468, 1324, 1261, 1186, 1102, 1026,
897, 828, 755, 728, 690;1H NMR: (300 MHz, DMSO-d6)d:
3.76 (s, 3H, OCH3), 6.98 (d, J= 9 Hz, 2H, 2ArH), 7.47–7.66
(m, 4H, H-5, H-6, 2ArH), 8.08 (d, J= 7.8 Hz, 1H, H-4),
8.19 (d, J= 7.5 Hz, 1H, H-7), 8.57 (br, 1H, NH), 8.78 (br,
1H, NH), 10.92 (s, 1H, NH); FABMS: 383 (MH+).
2.6. 2-[4-Amino-2-(4-ethoxyphenylamino)thiazol-5-
oyl]benzothiazole 3d
Yield 65%, m.p. 258–60 C Analysis: Found: C, 57.80: H,
4.18: N, 14.36%; Calc. for C19H16N4O2S2 (396.48): C, 57.55:
H, 4.07: N, 14.13%; IR (KBr) cm1: 3461, 3299, 2982, 2935,
1620, 1529, 1479, 1445, 1324, 1255, 1175, 1104, 1054, 899,
831, 763, 729;1H NMR: (300 MHz, DMSO-d6)d: 1.33 (t,
J= 6.9 Hz, 3H, CH3), 4.03 (quartet,J= 6.9 Hz, 2H, CH2),
6.96 (d, J= 9 Hz, 2H, 2ArH), 7.50–7.68 (m, 4H, H-5, H-6,
2ArH), 8.08 (d, J= 6 Hz, 1H, H-4), 8.20 (d, J= 6 Hz, 1H,
H-7), 8.56 (br, 1H, NH), 8.76 (br, 1H, NH), 10.89 (s, 1H,
NH); FABMS: 397 (MH+).
2.7. 2-[4-Amino-2-(4-methylphenylamino)thiazol-5-
oyl]benzothiazole 3e
Yield 60%, m.p. 282–85 C Analysis: Found: C, 58.74: H,
3.73: N, 15.43%; Calc. for C18H14N4OS2 (366.46): C, 58.99:
H, 3.85: N, 15.29%; IR (KBr) cm1: 3457, 3279, 3130, 3082,
2927, 2861, 1625, 1605, 1526, 1465, 1357, 1256, 1189, 1020,
892, 814, 761, 752, 621;1H NMR: (300 MHz, DMSO-d6) d:
2.30 (s, 3H, CH3), 7.20 (d, J= 8.1 Hz, 2H, 2ArH), 7.50–
7.68(m, 4H, H5, H-6, 2ArH), 8.08 (d,J= 7.8 Hz, 1H, H-4),
8.20 (d,J= 7.8 Hz, 1H, H-7), 8.60 (br, 1H, NH), 8.75 (br,
1H, NH), 10.98 (s, 1H, NH); FABMS: 367 (MH+).
2.8. 2-(4-Amino-2-ethylaminothiazol-5-oyl)benzothiazole 3f
Yield:65%,m.p. 255–56 C Analysis: Found: C, 51.41: H, 3.90:
N,18.55%; Calc. for C13H12N4OS2 (304.39): C, 51.29: H, 3.97:
N, 18.41%; IR (KBr) cm1: 3467, 3285, 3233, 3175, 3067,
2972, 2928, 2850, 1623, 1592, 1558, 1450, 1351, 1093, 882,
818, 757, 722;1H NMR: (300 MHz, DMSO-d6) d: 1.18 (t,
J= 7.0 Hz, 3H, CH3), 3.35 (br, 2H, CH2), 7.45–7.62 (m, 2H,
H-5, H-6),8.07 (d, J= 7.8 Hz, 1H, H-4), 8.16 (d, J= 7.8 Hz,
Table 2 Zones of inhibition of compounds 3a–i, standard
(Flucanazole) with different fungal strains.
Compound Zone of inhibition (mm)
Penicillium Aspergillus niger
3a 9 10
3b 11 9
3c 10 8
3d 9 9
3e 9 11
3f 11 10
3g 10 8
3h 8 8
3i 9 9
Flucanazole 12 12
NA Not active.
280 A. Yardily et al.1H, H-7), 8.39 (br, 1H, NH), 8.78 (br, 1H, NH), 8.94 (br, 1H,
NH); FABMS: 305 (MH+).
2.9. 2-(4-Amino-2-n-propylaminothiazol-5-oyl)benzothiazole 3g
Yield: 63%, m.p. 211–13 C; Analysis: Found: C, 52.95: H,
4.58: N, 17.45%; Calc. for C14H14N4OS2 (318.42): C, 52.80:
H, 4.43: N, 17.60%; IR (KBr) cm1: 3360, 3218, 3134, 3067,
2967, 2933, 2867, 1639, 1592, 1552, 1506, 1472, 1357,
1155,1093, 891, 823, 778, 683, 622; 1H NMR: (300 MHz,
DMSO-d6) d: 0.91 (t, J= 7.4 Hz, 3H, CH3), 1.58 (sextet,
J= 6.7 Hz, 2H, CH2), 3.38 (br, 2H, CH2),7.45–7.63 (m, 2H,
H-5, H-6), 8.06 (d, J= 6.9 Hz, 1H, H-4), 8.16 (d,
J= 7.5 Hz, 1H, H-7), 8.40(br, 1H, NH), 8.79 (br, 1H, NH),
8.95 (br, 1H, NH); 13C NMR: (75 MHz, DMSO-d6) d: 11.3,
21.9, 39.2, 91.1, 122.8, 123.8, 126.4, 126.8, 135.8, 139.3,
153.1, 169.5, 170.6, 171.3; FABMS: 319 (MH+).
2.10. 2-(4-Amino-2-n-butylaminothiazol-5-oyl)benzothiazole 3h
Yield: 65%, m.p. 182–185 C; Analysis: Found: C, 54.33: H,
4.93: N, 16.59; Calc. for C15H16N4OS2 (332.44): C, 54.19: H,
4.85: N, 16.85%; IR (KBr) cm1: 3352, 3279, 3198, 3162,
3050, 2962, 2917, 2858, 1634, 1600, 1539, 1465, 1357, 1309,
1152, 1081, 891, 818, 771, 737, 612; 1H NMR: (300 MHz,
DMSO-d6) d: 0.90 (t, J= 7.4 Hz, 3H, CH3), 1.35 (sextet,
J= 7.3 Hz, 2H, CH2), 1.51 (quintet, J= 7.1 Hz, 2H, CH2),
3.33 (br, 2H, CH2), 7.45–7.64 (m, 2H, H-5, H-6), 8.06 (d,
J= 7.8 Hz, 1H, H-4), 8.17(d, J= 7.5 Hz, 1H, H-7), 8.42
(br, 1H, NH), 8.92 (br, 1H, NH), 9.00 (br, 1H, NH); FABMS:
333 (MH+).
2.11. 2-(2-Allylamino-4-aminothiazol-5-oyl)benzothiazole 3i
Yield: 63%, m.p. 254–55 C; Analysis: Found: C, 53.29: H,
3.91: N, 17.57%; Calc. for C14H12N4OS2 (316.40): C, 53.14:
H, 3.82: N, 17.71%; IR (KBr) cm1:3486, 3299, 3238, 3083,
3050, 2967, 2933, 2894, 2842, 1626, 1599, 1565, 1506, 1458,
1322, 1094, 1013, 958, 891, 825, 764, 729; 1H NMR
(300 MHz, DMSO-d6) d: 4.02 (m, 2H, CH2), 5.11–5.32(m,
2H, CH2), 5.82–6.00 (m, 1H, CH), 7.45–7.64 (m, 2H, H-5,
H-6), 8.07 (d, J= 7.8 Hz, 1H, H-4), 8.17 (d, J= 7.5 Hz, 1H,
H-7), 8.43 (br, 1H, NH), 8.77 (br, 1H, NH), 9.09 (br, 1H,
NH); FABMS: 317 (MH+).Table 1 Zones of inhibition of compounds 3a–i, standard (penicilli
Compound Zone of inhibition(mm)
E. coli Klebsilla Bacillus
3a 13 12 8
3b 13 14 10
3c 8 NA NA
3d 9 NA NA
3e 8 NA NA
3f NA NA NA
3g 8 NA NA
3h 9 NA NA
3i NA NA NA
Control 15 12 12
NA Not active.3. Biological evaluation
3.1. Antimicrobial activity
The disk diffusion test was performed using standard proce-
dures. The inoculum suspension of each bacterial strain was
swabbed on the entire surface of Mueller–Hinton agar plates
(MHA, pH 7.3 ± 0.1, HiMedia). Sterile 6-mm ﬁlter paper
disks, which were previously impregnated with the compounds
(3a–i) dissolved in the solvent ethyl acetate, were aseptically
placed on MHA surfaces. Sterile paper disks impregnated with
10% DMSO were used as the negative controls, whereas a disk
containing penicillin was placed in the plate as a positive con-
trol. The plates were left at ambient temperature for 15 min to
allow excess prediffusion of extracts prior to incubation at
37 C for 24 h. Diameters of inhibition zones were measured.
In vitro antimicrobial activity was evaluated against eight
pathogenic microorganisms: Pseudomonas sp. MTCC-6538,
Escherichia coli MTCC-1671, Klebsiella sp. MTCC-7407,
Bacillus sp. MTCC-1134, Streptococcus sp. MTCC-1936 and
fungal strains of Penicillium sp. IC-201211 and Aspergillus ni-
ger IC-281011. For Mycobacterium tuberculosis MB- H37Rv,
1% cetrimide agar was used as the substrate and sputum swab
containing microbial population was made in the plate. Then
the disks impregnated with compounds were placed in the
plates and the zone of inhibition was measured.n) with different bacterial strains.
Streptococcus Staphyllococcus Pseudomonas
7 11 10
11 14 13
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
NA NA NA
12 10 10
Table 3 Zones of inhibition of compounds 3a–i, with myco-
bacterium tuberculosis.
Compound Zone of inhibition (mm)
0.5 mg 1 mg 1.5 mg 2 mg Control
3a NA NA 2 3 3
3b NA 1 2 4 3
3c NA NA NA 2 3
3d 3 5 6 8 3
3e NA 3 4 4 2
3f 3 6 7 8 3
3g NA NA NA NA NA
3h NA NA 2 2 4
3i 2 3 3 5 2
NA Not Active.
Table 4 2-(4-Amino-2-aryl/alkylaminothiazol-5-oyl)benzo-
thiazoles 3a–i.
Compound R
3a C6H5–
3b 4-ClC6H4–
3c 4-MeOC6H4–
3d 4-EtOC6H4–
3e 4-MeC6H4–
3f C2H5–
3g N-C3H7–
3h N-C4H9–
3i Allyl–
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The structures of all the compounds were established on the
basis of elemental analysis, IR, 1H NMR, 13C NMR and mass
spectral data and tested for in vitro antimicrobial activity. The
antibacterial and antifungal screening results of these com-
pounds are shown in Table 1 and Table 2 ‘respectively’. The
drug susceptibility test against Mycobacterium tuberculosis is
shown in Table 3.From the above-mentioned results, it may be concluded
that the derivatives of benzothiazoles possess moderate to po-
tent antimicrobial activity. Compounds 3a and 3b were found
to be more effective against all bacterial strains and most of the
compounds were active against E. coli. All the compounds
were found to have moderate antifungal activity. When tested
against M. tuberculosis, compounds 3d, 3f, and 3i showed the
maximum activity when compared with control. Compounds
3b, 3e, and 3h showed moderate activity. Thus the study ascer-
tains the value of benzothiazole drugs which could be of con-
siderable interest for the development of new drugs.Acknowledgements
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